Details of Grant 

EPSRC Reference:	EP/F010516/1
Title:	Accelerating rational drug design with multi-threaded array processors
Principal Investigator:	Manby, Professor FR
Other Investigators:	Mulholland, Professor AJ
Researcher Co-Investigators:	Dr CJ Woods
Project Partners:	ClearSpeed Technology
Department:	Chemistry
Organisation:	University of Bristol
Scheme:	Standard Research
Starts:	02 July 2007	Ends:	01 January 2009	Value (£):	124,565
EPSRC Research Topic Classifications:	Biological & Medicinal Chem. High Performance Computing
EPSRC Industrial Sector Classifications:	Healthcare
Related Grants:
Panel History:	Panel Date Panel Name Outcome 16 Apr 2007 HPC Software Development (Science) Announced
Summary on Grant Application Form
Pharmaceutical exports contribute over 12 billion to the UK economy each year (UK Trade and Investment figures for 2004). However, this success is threatened by the decline in the number of successful new drugs developed each year (The American Food and Drug Agency approved 230 drugs in 1997 and only 28 last year). This sharp decline indicates the need for new ways to develop pharmaceuticals. Computational chemistry has the potential to deliver the necessary step-change. Currently used methods for computing binding affinities of drug molecules to protein hosts are efficient but lack reliability because they fail to capture the essential physics. Quantum mechanics provides a physically accurate representation of the interactions, but these calculations are currently too computationally expensive for commercial use. We will use our existing expertise to implement quantum mechanical methods parallelized over thousands of processor cores. This will be achieved firstly by parallelization over the 100-core processor architecture of ClearSpeed plc, and secondly over clusters of nodes containing this acceleration technology. The techniques that we will develop will be applicable to emergent multicore designs from companies such as Intel, and have the potential to make a major contribution to rational drug design.
Key Findings
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Potential use in non-academic contexts
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Impacts
Description This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk Summary Date Materialised
Sectors submitted by the Researcher
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Project URL:
Further Information:
Organisation Website:	http://www.bris.ac.uk